RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Lirunex vs Next Step Funded

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

LRNX

Lirunex

NXSF

Next Step Funded

LIRUNEX

METRIC

NEXT STEP FUNDED

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

LIRUNEX DETAILS

STEPS: -phase

NEXT STEP FUNDED DETAILS

STEPS: -phase

Lirunex PROS

+Country of operation is listed as Hong Kong, indicating an established international jurisdiction.
+A registered tag suggests some formal industry presence.
+No confirmed below-average financial metrics are currently on record.
+Listing on a comparison platform indicates an intent toward transparency.

Lirunex CONS

−No trading or financial metrics are available to evaluate this firm objectively.
−Without data on profit split, funding, or costs, no comparison to industry averages is possible.
−Traders cannot assess payout speed, drawdown rules, or profit targets from available data.

Next Step Funded PROS

+No data is available to identify any pros for Next Step Funded at this time.
+No platform or market information is provided to assess trading conditions.
+No funding or cost data is available to compare against industry benchmarks.
+No profit split or payout data exists to evaluate trader compensation.

Next Step Funded CONS

−No data whatsoever is available for Next Step Funded, making any evaluation impossible.
−Complete absence of key metrics such as drawdown, profit split, and funding is a significant transparency concern.
−Traders have no basis for comparison against industry averages with zero data disclosed.

PROPDNA VERDICT